A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC)

CompletedOBSERVATIONAL
Enrollment

776

Participants

Timeline

Start Date

November 15, 2018

Primary Completion Date

March 16, 2019

Study Completion Date

March 16, 2019

Conditions
Non-melanoma Skin Cancer
Interventions
RADIATION

SRT-100

The SRT-100™ is a simple painless non-invasive in-office procedure that is approved by the U.S. Food and Drug Administration (U.S. FDA) to treat keloids caused by surgery or injury by delivering a precise, calibrated dose of Superficial Radiation Therapy (SRT) that only goes skin deep.

Trial Locations (1)

33437

Dermatology and Dermatological Surgery, Boynton Beach

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sensus Healthcare

INDUSTRY

NCT03693937 - A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC) | Biotech Hunter | Biotech Hunter